Project ALS is pleased to share that the FDA has approved the drug edaravone – the first approved ALS treatment in over 20 years.
Edaravone, a free radical scavenger, appears to react with nerve-damaging compounds generated as part of the disease process. After six months of treatment, on top of standard-of-care, data showed the intravenous drug reduced the rate of functional decline in patients by about a third.
Read more
Carol Kleiner: Medicine Woman
Carol Kleiner was a warrior: wife, mother, grandmother, friend, rower, leader, and a woman who knew what she wanted. If not for Carol and
December 23, 2025
No Comments
